For research use only
| Cat No. | ABC-TC3579 |
| Product Type | Vascular Cells |
| Cell Type | Endothelial |
| Species | Human |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | Coronary Artery Tissue |
| Disease | Type II Diabete |
| Storage | Liquid Nitrogen |
Human Coronary Artery Endothelial Cells, Diabetic Type II model dysfunction for angiogenesis, barrier, and inflammation assays under diabetic cues.
Human Coronary Artery Endothelial Cells (HCAEC)-Diabetic Type II are isolated from donors diagnosed with Type 2 Diabetes and cryopreserved at early passage to ensure high viability. These disease-affected cells are cultured in the same optimized medium as Normal Human Coronary Artery Endothelial Cells, ensuring consistency in experimental conditions. These cells provide a valuable model for investigating the vascular impact of Type 2 Diabetes. Repeated freeze-thaw cycles should be avoided to maintain cell function and integrity. The cells undergo rigorous screening and isolation procedures, and are rigorously tested to ensure they are free of contamination from HIV-1, HBV, HCV, syphilis, mycoplasma, fungi, yeast, and bacteria.
| Product Code | Human Coronary Artery Endothelial Cells Type II Diabetes, HCAECs T2DM, Coronary ECs Diabetic Type II, Human Coronary Endothelial Cells T2DM, Diabetic Type II Coronary ECs |
| Species | Human |
| Cat.No | ABC-TC3579 |
| Product Category | Primary Cells |
| Size/Quantity | 1 vial |
| Cell Type | Endothelial |
| Growth Mode | Adherent |
| Shipping Info | Dry Ice |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | Coronary Artery Tissue |
| Disease | Type II Diabete |
| Biosafety Level | 1 |
| Storage | Liquid Nitrogen |
| Product Type | Vascular Cells |
| Quality Control | All cells test negative for mycoplasma, bacteria, yeast, and fungi. |
Human coronary artery endothelial cells (Type 2 Diabetes) provide an invaluable in vitro model to study vascular dysfunction and endothelial impairment associated with diabetes mellitus. These cells are especially useful for investigating molecular mechanisms underlying diabetic vascular complications such as atherosclerosis, inflammation, and impaired angiogenesis. They help elucidate endothelial cell responses to hyperglycemia and contribute to the development of therapeutic strategies targeting diabetic cardiovascular diseases.
When you publish your research, please cite our product as “AcceGen Biotech Cat.# XXX-0000”. In return, we’ll give you a $200 coupon. Simply click here and submit your paper’s PubMed ID (PMID).